Our research interests lie primarily in the area of asymmetric organic synthesis with a strong focus on the development of new methods to access organic scaffolds that are not efficiently made using conventional batch reactions. We are currently applying CFS techniques to new supported catalysts and in-situ generated sensitive reagents in an effort to provide additional tools for the manufacturing sector.

The use of CFS is omnipresent in our research program. We are currently investigating macrocyclization processes in flow, particularly for performing reactions at high concentrations, for solvent recycling and tandem reaction processes. We are also exploiting the benefits of CFS for discovering new photochemical transformations and exploring new visible light mediated chemical processes using alternative metal sensitizers.

We are involved in the optimization of catalytic reactions requiring a large set of parameters using CFS and we focus on the design of innovative microfluidic strategies in catalysis for the synthesis of unique chiral entities.

Our research program aims at utilizing CFS experiments with novel immobilized transition metal catalysts in order to perform C–N bond forming reactions and to address the synthesis of this important class of compounds for the pharmaceutical manufacturing sector.

We have achieved a solid recognition in the fields of peptide mimicry, medicinal chemistry and the synthesis of amino acids and heterocycles. We are currently pursuing the application of CFS in the synthesis of peptides and peptidomimetics as well as analytical techniques based on flow methodology for the evaluation of drug candidates.

Our group has developed an expertise in multiphase reaction engineering. Some of our current projects involve the hydrodynamics of heavy oil hydroprocessors, the development of micro-reactors for intensifying the synthesis of fine chemicals and pharmaceuticals and the synthesis of gas hydrates for natural gas transportation.

We develop spectroscopic biosensors for the analysis of biomolecules present in medical samples. We also study the properties of nano- and microstructures to improve the sensitivity of instruments and the properties of surface chemistry to improve analysis selectivity in biological fluids.

Our research program relates to fluidization, catalysis and process technology. Among our ongoing projects, we are adapting the industrial batch transesterification process for biodiesel production to a continuous process.

Our research group is a world-class expert in biomimetic surfaces and biointerfaces for their applications in nanomedicine, regenerative medicine and microfluidic Lab-on-a-Chip platforms for bioassays.

Our research focuses on the development of new bionanotechnologies inspired by Nature to improve the detection of tumours and to deliver anti-cancer treatments more effectively. Our expertise in CFS ranges from the kinetic analysis of protein folding mechanisms to the development of CFS monitoring of various analytes.

Our group is internationally recognized for our studies of intermolecular interactions in controlling the structure and properties of materials. We focus on designing and synthesizing new compounds using CFS to optimize molecular organization in thin layers for molecular devices, such as solar cells.